INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Institutua
![Foto de INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA](/img/noimage.png)
![Foto de Centro de Investigación Biomédica en Red de Cáncer](/img/noimage_org.png)
Centro de Investigación Biomédica en Red de Cáncer
Madrid, EspañaCentro de Investigación Biomédica en Red de Cáncer-ko ikertzaileekin lankidetzan egindako argitalpenak (129)
2024
-
CD20+ T cells in monoclonal B cell lymphocytosis and chronic lymphocytic leukemia: frequency, phenotype and association with disease progression
Frontiers in Oncology, Vol. 14
-
Chromosomal breaks: another differential gap between early-onset and late-onset colorectal cancers
British Journal of Surgery, Vol. 111, Núm. 3
-
Clinical impact of the TPSAB1 genotype in mast cell diseases: A REMA study in a cohort of 959 individuals
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 79, Núm. 3, pp. 711-723
-
Differentially Expressed Genes Involved in Primary Resistance to Immunotherapy in Patients with Advanced-Stage Pulmonary Cancer
International Journal of Molecular Sciences, Vol. 25, Núm. 4
-
ERK5 Interacts with Mitochondrial Glutaminase and Regulates Its Expression
International Journal of Molecular Sciences, Vol. 25, Núm. 6
-
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo
Science translational medicine, Vol. 16, Núm. 734, pp. eadg7962
-
Functional proteomics based on protein microarray technology for biomedical research
Advances in Protein Chemistry and Structural Biology (Academic Press Inc.), pp. 49-65
-
Immune and stromal transcriptional patterns that influence the outcome of classic Hodgkin lymphoma
Scientific Reports, Vol. 14, Núm. 1
-
Impact of the kinetics of circulating anti-CD19 CAR-T cells and their populations on the outcome of DLBCL patients
Blood cancer journal
-
LT and SOX9 expression are associated with gene sets that distinguish Merkel cell polyomavirus (MCPyV)-positive and MCPyV-negative Merkel cell carcinoma
The British journal of dermatology, Vol. 190, Núm. 6, pp. 876-884
-
Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry
Haematologica, Vol. 109, Núm. 1, pp. 115-128
-
Paired Primary and Recurrent Rhabdoid Meningiomas: Cytogenetic Alterations, BAP1 Gene Expression Profile and Patient Outcome
Biology, Vol. 13, Núm. 5
-
Prevalence and Consequences of a Delayed Diagnosis in Multiple Myeloma: A Single Institution Experience
Clinical Lymphoma, Myeloma and Leukemia, Vol. 24, Núm. 7, pp. 478-483
-
Quantification of cyclin D1 and D2 proteins in multiple myeloma identifies different expression patterns from those revealed by gene expression profiling
Haematologica, Vol. 109, Núm. 3, pp. 877-887
-
RhoA downregulation in the murine intestinal epithelium results in chronic Wnt activation and increased tumorigenesis
iScience, Vol. 27, Núm. 4
-
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma
Blood cancer discovery, Vol. 5, Núm. 3, pp. 146-152
-
Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia
American Journal of Hematology, Vol. 99, Núm. 4, pp. 586-595
-
Single-cell transcriptional profile of CD34+ hematopoietic progenitor cells from del(5q) myelodysplastic syndromes and impact of lenalidomide
Nature Communications, Vol. 15, Núm. 1
-
T-cell immune profile in blood of systemic mastocytosis: Association with disease features
Allergy: European Journal of Allergy and Clinical Immunology
-
Tinostamustine (EDO-S101), an Alkylating Deacetylase Inhibitor, Enhances the Efficacy of Daratumumab in Multiple Myeloma by Upregulation of CD38 and NKG2D Ligands
International Journal of Molecular Sciences, Vol. 25, Núm. 9